ligand articles & resources on Made-in-China.com

MIT Chemists Devised a Way to Trap Carbon Dioxide and Transform It Into Organic Compounds

Mar 10, 2014

MIT chemists have devised a way to trap carbon dioxide and transform it into useful organic compounds, using a simple metal complex. More work is needed to understand and optimize the reaction, but one day this approach could offer an ...

Tags: Cleaner Energy, Catalyst, Consumer Electronics

The Behavior of Protons in Reactions Important to Energy Storage and Production

Jan 13, 2014

By directly comparing three closely related catalysts, scientists at the Center for Molecular Electrocatalysis established that hydrogen production speed and efficiency are influenced by the molecules' structure and proton relay ...

Tags: catalysts, hydrogen production speed, proton relay arrangement

Trevena Announced Today Initiation of Dosing in BLAST-AHF

Jan 10, 2014

Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center ...

Tags: Trevena, GPCR biased ligands, BLAST-AHF, acute heart failure

Innate Pharma Has Started a New Program Named Iph43, to Develop an Anti-Mica

Nov 20, 2013

Innate Pharma has started a new program named IPH43, to develop an anti-MICA therapeutic antibody in oncology. The program is the newest to emerge from the company's discovery platform. MICA, which is highly polymorphic ligand of the NK ...

Tags: Innate Pharma, Anti-Mica Antibody

CTAD Can Been Identified by Cognoptix Eye Test's Positive Results

Nov 19, 2013

Cognoptix disclosed at the ‘Clinical Trials on Alzheimer’s Disease’ (CTAD) scientific meeting the strong results of a multi-site clinical trial of its SAPPHIRE II eye test, which is designed to identify Alzheimer’s ...

Tags: Cognoptix Eye, Alzheimer's Disease

Eddingpharm Received License From Ablynx to Develop and Commercialize Its Anti-RANKL

Oct 22, 2013

Chinese specialty pharmaceutical firm Eddingpharm has received an exclusive, royalty-bearing license from Ablynx to develop and commercialize its anti-RANKL Nanobody, ALX-0141, in China, the Hong Kong and Macao Special Administrative ...

Tags: Eddingpharm, Anti-Rankl Nanobody

Zydus Cadila and Pieris Have Entered Into an Alliance

Oct 18, 2013

Global pharmaceutical company Zydus Cadila and Pieris, a therapeutic protein research and development company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics. The ...

Tags: Zydus, Pieris, Anticalin-Based Protein Therapeutics

Medtronic's Interventional Spine Division Has Signed a Three-Year Agreement

Jul 18, 2013

Medtronic's Interventional Spine division has signed a three-year agreement to promote Amgen's Prolia (denosumab) to orthopedic and spine specialists in the US. Prolia is approved in the US to treat postmenopausal women with osteoporosis ...

Tags: Interventional Spine division, Amgen's Prolia

Rib-X Pharmaceuticals Has Commenced Phase 3 Trial of a Captisol-Enabled Intravenous

May 16, 2013

Rib-X Pharmaceuticals, Ligand Pharmaceuticals' partner, has commenced Phase 3 trial of a Captisol-enabled intravenous (IV) formulation of delafloxacin to treat acute bacterial skin and skin structure infections (ABSSSI). According to the ...

Tags: Rib-X, Pharmaceuticals

Apogenix's Apocept Has Won FDA Orphan Drug Designation to Treat MDS

Feb 18, 2013

Clinical stage biopharmaceutical company Apogenix's Apocept (APG101) has won FDA orphan drug designation to treat myelodysplastic syndromes (MDS). Apogenix also announced the commencement of Apocept Phase I trial in MDS patients in ...

Tags: FDA, orphan drug, biopharmaceutical

BASF Coatings GmbH Has Been Granted a Patent for Electrocoat

Feb 16, 2013

U.S. 8,192,603 B2 BASF Coatings GmbH has been granted a patent for an aqueous coating composition comprised of a metal oxide selected from the group consisting of bismuth oxide, vanadium oxide, manganese oxide, cobalt oxide, zinc ...

Tags: BASF, patent, aqueous coating composition

Priaxon Has Signed Research Collaboration with GSK to Develop Small Molecule Modulators

Jan 10, 2013

Priaxon has signed research collaboration with GlaxoSmithKline (GSK) to develop small molecule modulators for various protein-protein-interactions (PPIs). The collaboration will utilize Priaxon's small molecule drug discovery knowledge in ...

Tags: Priaxon, GSK, drug discovery, clinical development, therapeutic areas

The BZA/CE Is an Investigational Therapy Developed by Wyeth Pharmaceuticals

Dec 17, 2012

Pfizer and Ligand Pharmaceuticals have announced the FDA acceptance of bazedoxifene/conjugated estrogens (BZA/CE) new drug application (NDA) for review. The BZA/CE is an investigational therapy developed by Wyeth Pharmaceuticals to tackle ...

Tags: estrogens NDA, Pharmaceuticals, FDA, menopausal symptoms

GSK Gained FDA Priority Review Status for The Supplemental New Drug Application

Dec 7, 2012

GlaxoSmithKline (GSK), Ligand Pharmaceuticals' partner, has gained FDA priority review status for the supplemental new drug application for Promacta to treat thrombocytopenia in adult patients with chronic hepatitis C virus infection. ...

Tags: GlaxoSmithKline, GSK, promacta, thrombocytopenia

Onyx Pharmaceuticals Gained FDA Approval for Kyprolis for Injection

Nov 28, 2012

Onyx Pharmaceuticals, a licensee of Ligand Pharmaceuticals, has gained FDA approval for Kyprolis (carfilzomib) for injection. Kyprolis is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have ...

Tags: Onyx Pharmaceuticals, Ligand Pharmaceuticals, Kyprolis

ligand

Related Products